Galectin-1 Modulates the Fusogenic Activity of Placental Endogenous Retroviral Envelopes
Viruses · 2023
DOI: 10.3390/v15122441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Caroline Toudic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Département des Sciences Biologiques and Centre d'excellence en Recherche sur les Maladies Orphelines-Fondation Courtois, Université du Québec à Mont…. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Placenta. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, National Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Syncytin-1 and -2 are glycoproteins encoded by human endogenous retrovirus (hERV) that, through their fusogenic properties, are needed for the formation of the placental syncytiotrophoblast. Previous studies suggested that these proteins, in addition to the EnvP(b) envelope protein, are also involved in other cell fusion events. Since galectin-1 is a β-galactoside-binding protein associated with cytotrophoblast fusion during placental development, we previously tested its effect on Syncytin-mediated cell fusion and showed that this protein differently modulates the fusogenic potential of Syncytin-1 and -2. Herein, we were interested in comparing the impact of galectin-1 on hERV envelope proteins in different cellular contexts. Using a syncytium assay, we first demonstrated that galectin-1 increased the fusion of Syncytin-2- and EnvP(b)-expressing cells. We then tested the infectivity of Syncytin-1 and -2 vs. VSV-G-pseudotyped viruses toward Cos-7 and various human cell lines. In the presence of galectin-1, infection of Syncytin-2-pseudotyped viruses augmented for all cell lines. In contrast, the impact of galectin-1 on the infectivity of Syncytin-1-pseudotyped viruses varied, being cell- and dose-dependent. In this study, we report the functional associations between three hERV envelope proteins and galectin-1, which should provide information on the fusogenic activity of these proteins in the placenta and other biological and pathological processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département des Sciences Biologiques and Centre d'excellence en Recherche sur les Maladies Orphelines-Fondation Courtois, Université du Québec à Montréal, Montréal, QC H3C 3P8, Canada.
- Robert-Koch Institute, 13353 Berlin, Germany.
- Glycobiology and Bioimaging Laboratory, Research Centre for Infectious Diseases and Axe Maladies Infectieuses et Immunitaires, Laval University, Quebec City, QC G1V 0A6, Canada.
- Regroupement Intersectoriel de Recherche en Santé de l'Université du Québec, Montréal, QC H2X 1E3, Canada.
ORCID-Profile: Benoit Barbeau
Förderung
- CIHR
- National Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Toudic, C., Maurer, M., St-Pierre, G., Xiao, Y., Bannert, N., Lafond, J., Rassart, É., Sato, S., & Barbeau, B. (2023). Galectin-1 Modulates the Fusogenic Activity of Placental Endogenous Retroviral Envelopes. Viruses. https://doi.org/10.3390/v15122441
Vancouver
Toudic C, Maurer M, St-Pierre G, Xiao Y, Bannert N, Lafond J, et al. Galectin-1 Modulates the Fusogenic Activity of Placental Endogenous Retroviral Envelopes. Viruses. 2023. doi:10.3390/v15122441
BibTeX
@article{Toudic2023,
author = {Toudic, Caroline and Maurer, Maike and St-Pierre, Guillaume and Xiao, Yong and Bannert, Norbert and Lafond, Julie and Rassart, Éric and Sato, Sachiko and Barbeau, Benoit},
title = {Galectin-1 Modulates the Fusogenic Activity of Placental Endogenous Retroviral Envelopes},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15122441}
}
EUVIMED